Path-to-market + Positioning
IDEA Pharma: SAI’s Path-to-market Strategy Division
Choosing a path to market successfully is a discipline, and like any discipline, it is best performed by specialists. We work with biopharma clients to develop options and strategies for the “best” path to market: clinically, regulatory, and commercially.
our approach
Increase Your Chance of Getting to Market and Achieving Success on Market
We understand that every biopharma client has unique opportunities and challenges, which is why our path-to-market strategy solutions are tailored to meet your specific business needs. We craft a best-in-class strategy that helps every molecule reach its potential.
Whether you are navigating early-stage development, market entry, or life cycle management, our approach is always innovation-focused. By combing our deep therapeutic area knowledge with robust market insights and IDEA-forward methodologies, we deliver strategies and decision support to maximize probability of success.
Nobody understands pharma innovation quite like us. We always look for opportunities for your product to outperform the market and have supported molecules that have become some of the biggest brands and commercial successes of our industry.
It All Starts With Strategy:
From Foundations to Execution
Strategic Inputs
Strategic Inputs
- Business Development Advisory Panels
- Disease State Advisory Panels
- Strategic Patient Journey
- Segmentation Strategy
- Disease Space Scenario Mapping
- Competitive Simulation
- Clinical Outcome Scenario Mapping
Core Strategic Offerings
Core Strategic Offerings
- Strategic Positioning
- Value Proposition
- Path-to-market Strategy (FIVE-X)
- TOP/TPP Exploration and Alignment
- Portfolio Vision
- Portfolio Strategy
- Segmentation & Co-positioning Strategy
Strategic Outputs
Strategic Outputs
- Brand Identity and Essence
- Strategic Communications Platform
- Market-shaping Strategy
- Storytelling and Messaging
- Scientific Communications Platform
- Medical Affairs Strategy
Why Choose IDEA Pharma, a Division of SAI MedPartners, for Strategic Consulting?
Our Unique Advantages:
Deep Sector Insights
Deep understanding of the commercial and regulatory landscapes to shape propositions for your asset.
Inspirational Creativity
We develop and explore options that are meaningful different, enabling each asset to meet its full potential.
Consultancy Rigor
Scientific rigor applied by a cross-functional team that understands the commercial potential of clinical performance.
Decision Support
Our pivotal decision support services enable clinical, regulatory, and commercial strategies for transformative outcomes.
Senior Engagement
Senior-level path-to-market and positioning experts are hands-on in every project, delivering top-tier strategies and results.
IDEA’s FIVE-X
A Proprietary Option Evaluation Philosophy
The FIVE-X framework integrates creativity and sustainability into the decision-making process by enabling teams to systematically and innovatively explore market pathways. It facilitates portfolio-level decision-making by presenting clear opportunity and risk profiles for each path, while offering lifecycle plans as contingent options rather than rigid choices. Ultimately, FIVE-X empowers teams with evidence-driven strategies to make better, more informed decisions.
FASTEST
Quickest
path-to-market
INDEX PATIENT
Precision medicine: if you only
got paid if the drug works
VALUE
The lowest-cost
path-to-market
EXPECTED
What the average
company would do
UNEXPECTED
An unexpected
path-to-market
Explore the Benefits of Partnering with SAI MedPartners
Gain the insights and guidance needed to navigate complex decisions in the global healthcare market. With tailored strategies, deep expertise, and actionable solutions, IDEA Pharma, a division of SAI MedPartners, is your trusted partner for growth and success.